Skip to main content
Equibles

VOYA INVESTMENT MANAGEMENT LLC

Position in MYGN — Myriad Genetics Inc

CIK 1068837 ATLANTA, GA
Back to MYGN Full portfolio

Position in MYGN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$842,647
+$145,593 QoQ
Shares Held
147,574
-4.7% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 196 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

VOYA INVESTMENT MANAGEMENT LLC holds $921,246,084 across 28 Diagnostics & Research names. MYGN ranks #23 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 WAT
Waters Corp /De/
 653,967 $245,263,782
2 DHR
Danaher Corp /De/
 732,006 $139,432,501
3 TMO
Thermo Fisher Scientific Inc.
 257,632 $129,166,378
4 GH
Guardant Health, Inc.
 480,839 $72,140,274
5 NTRA
Natera, Inc.
 252,610 $68,570,983
6 IDXX
Idexx Laboratories Inc /De
 95,942 $50,507,705
7 ICLR
Icon PLC
 289,918 $50,361,655
8 DGX
Quest Diagnostics Inc
 211,496 $44,826,576

All Filings in MYGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $842,647 147,574
2026-03-31 $697,054 154,901
2025-12-31 $640,399 104,130
2025-09-30 $740,236 102,384
2025-06-30 $382,112 71,961
2025-03-31 $643,713 72,572
2024-12-31 $655,091 47,782
2024-09-30 $1,043,038 38,081
2024-06-30 $951,151 38,886
2024-03-31 $876,699 41,121
2023-12-31 $893,550 46,685
2023-09-30 $842,003 52,494
2023-06-30 $1,208,883 52,152
2023-03-31 $1,176,715 50,655
2022-12-31 $777,619 53,592
2022-09-30 $1,221,787 64,035
2022-06-30 $1,163,515 64,035
2022-03-31 $1,628,650 64,629
2021-12-31 $1,773,547 64,259
2021-09-30 $1,765,261 54,669
2021-06-30 $1,633,735 53,425
2021-03-31 $1,346,011 44,204
2020-12-31 $873,438 44,180
2020-09-30 $497,071 38,119
2020-06-30 $435,297 38,386
2020-03-31 $698,442 48,808